HKPD logo

CELLYAN BIOTECHNOLOGY CO-A

HKPDNASDAQ
🏆 #5023 by market capUS Equity
——
Quote unavailable
🔔
Track HKPD
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$5M
Small Cap
📈Revenue Growth (YoY)
-33.9%
Declining
📊Gross Margin
10.3%
Thin
💵FCF Margin
-5.9%
Thin
⚖️P/S Ratio
0.4x
Cheap
Otter Score
—
Insufficient data
No chart data available for HKPD.

Trading Snapshot

Day Range
—
52-Week Range
$1.62 – $29.00
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
2.1M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$13M
Last Q Revenue
$6M
P/E Ratio
-5.3
P/S Ratio
0.4x
EPS (TTM)
$-0.63
Dividend Yield
0.00%
Dilution (1yr)
+227.3%
HKPD logo

CELLYAN BIOTECHNOLOGY CO-A

HKPD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$13M▼ −33.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
10.3%▼ −13.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$995K▼ −853.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$787K▼ −290.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
36.0M▲ +227.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$1M▲ +$1M YoY
StockOtter · stockotter.space

About CELLYAN BIOTECHNOLOGY CO-A

Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.